Amid a global landscape reshaped by the COVID-19 pandemic, scientific inquiry into coronaviruses has surged, focusing predominantly on betacoronaviruses and their spillover mechanisms. Yet, alphacoronaviruses, a genus with significant but less explored zoonotic and pandemic potential, have remained relatively understudied. New research published in Nature reveals groundbreaking insights into these viruses, specifically highlighting their complex receptor usage and implications for future viral spillover events.
Traditionally, alphacoronaviruses have been associated with a limited set of receptors, primarily human aminopeptidase N (APN) and angiotensin-converting enzyme 2 (ACE2), which mediate viral entry into host cells. However, a comprehensive genus-wide analysis reveals that receptor usage among alphacoronaviruses is far more heterogenous than previously understood. These findings challenge earlier dogma and suggest that the paradigm of alphacoronavirus host engagement is more intricate, with critical consequences for how these viruses adapt and spill over into new hosts.
This study utilized an innovative approach combining pseudovirus systems and receptor assays, creating a vast library of alphacoronavirus spike protein sequences derived from diverse bat reservoir species. Strikingly, only 2 out of 25 bat-derived spike proteins effectively utilized known alpha-CoV receptors such as APN or ACE2. This disparity pointed researchers toward the existence of alternative receptor pathways facilitating viral entry—a discovery that reshapes our understanding of alphacoronavirus biology.
One remarkable example underlined by this research is CcCoV-KY43, a heart-nosed bat alphacoronavirus from Kenya. Unlike many bat coronaviruses, this virus exhibits partial tropism for human cells, raising alarms about its zoonotic potential. Identification of its receptor, carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), offers crucial insights into virus–host interactions that might enable cross-species transmission. CEACAM6, a member of an immunoglobulin-like adhesion protein family, is abundantly expressed on mucosal epithelial surfaces, positioning it as an ideal viral attachment target.
The discovery of CEACAM6 as a functional receptor adds to an emerging narrative that coronaviruses exploit a diverse range of immunoglobulin superfamily proteins for cellular entry. This receptor family’s widespread presence on barrier tissues underscores its susceptibility to viral exploitation, paralleling mechanisms observed in other pathogens ranging from fungal species like Candida albicans to numerous Gram-negative bacteria, which similarly use CEACAMs to adhere to host cells.
This novel receptor identification provides a key piece in the puzzle for understanding alphacoronavirus host specificity and cross-species transmission dynamics. Importantly, the study also explored receptor usage beyond African bat viruses, finding evidence for CEACAM6 utilization across alphacoronaviruses from Europe and East Asia, thereby indicating broader geographic and evolutionary relevance.
With regard to modeling zoonotic risk, the research integrates computational methods, including machine learning algorithms, to predict viral zoonotic potential based on sequence data. By coupling unbiased sequence selection with high-throughput receptor screening, structural biology, and field-based epidemiological surveys, the investigators have developed a robust framework for pandemic preparedness. This integrative strategy moves the field closer to predicting and preempting future spillover events before they manifest as outbreaks.
Sero-surveillance conducted in human populations from regions endemic to these alphacoronaviruses further supports the potential for unnoticed spillover events. The implication that human exposure to these bat viruses is occurring, even if only sporadically, calls for heightened surveillance and deeper immunological characterization to understand population-level risks.
The enriched understanding of viral receptor engagement has pragmatic ramifications for designing broad-spectrum antivirals and vaccines. Targeting viral interactions with diverse receptors such as CEACAM6 may provide new avenues to curtail infections before they escalate into widespread epidemics. Moreover, elucidating these pathways deepens our grasp of coronavirus evolution, revealing how viral surface proteins adapt to exploit immunoglobulin superfamily receptors selectively.
Amid mounting evidence of multiple receptor usage and viral plasticity, this work reinforces the urgency to expand ecological and molecular surveillance of alphacoronaviruses. Discovering nuanced receptor relationships clarifies why some bat coronavirus lineages successfully jump to humans or livestock while others remain confined to their natural hosts, guiding focused risk assessment and intervention strategies.
The identification of CEACAM6 as a receptor not only extends the catalog of coronavirus entry points but also highlights the multifaceted nature of viral tropism. Furthermore, the receptor’s immune modulatory roles may influence host responses post-infection, raising important questions about pathogenesis that warrant further investigation.
In sum, this comprehensive study delivers a critical advancement in coronavirus research by unveiling a previously uncharacterized mode of alphacoronavirus entry. Through a multidisciplinary approach that blends virology, molecular biology, computational analysis, and epidemiology, researchers have charted new territory in understanding how zoonotic viruses might spill over from bats to humans, equipping the global health community with knowledge vital for future pandemic preparedness.
Subject of Research: Examination of receptor usage and zoonotic potential of alphacoronaviruses, with a focus on the discovery of the human CEACAM6 receptor utilized by heart-nosed bat alphacoronaviruses.
Article Title: Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells.
Article References:
Gallo, G., Di Nardo, A., Lugano, D. et al. Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells. Nature (2026). https://doi.org/10.1038/s41586-026-10394-x
Image Credits: AI Generated
